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There are several transforming growth factor-b (TGF-b) pathways in the nematode Caenorhabditis elegans. One of these
pathways regulates body length and is composed of the ligand DBL-1, serine/threonine protein kinase receptors SMA-6 and
DAF-4, and cytoplasmic signaling components SMA-2, SMA-3, and SMA-4. To further examine the molecular mechanisms
of body-length regulation in the nematode by the TGF-b pathway, we examined the regional requirement for the type-I
receptor SMA-6. Using a SMA-6::GFP (green fluorescent protein) reporter gene, sma-6 was highly expressed in the
hypodermis, unlike the type-II receptor DAF-4, which is reported to be ubiquitously expressed. We then examined the
ability of SMA-6 expression in different regions of the C. elegans body to rescue the sma-6 phenotype (small) and found that
hypodermal expression of SMA-6 is necessary and sufficient for the growth and maintenance of body length. We also
demonstrate that GATA sequences in the sma-6 promoter contribute to the hypodermal expression of sma-6.
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f
b
t
s
y
s
i
t
t
S
p
c
i
o
b
tINTRODUCTION
Intercellular signaling by growth factors coordinates
many developmental decisions controlling the growth, dif-
ferentiation, and morphogenesis of metazoans. The trans-
forming growth factor-b (TGF-b) superfamily of secreted
proteins has key roles in these signaling networks in many
organisms. An accepted model for signaling by the TGF-b
family has emerged recently (reviewed in Itoh et al., 2000;
Massague et al., 2000; Massague and Chen, 2000; Massague
and Wotton, 2000; Zimmerman and Padgett, 2000). The
basic components of this model are two receptor serine/
threonine protein kinases (receptor types I and II) and the
1 Present address: Laboratory of Regeneration Biology, Depart-
ment of Life Science Faculty of Science, Himeji Institute of
Technology, Harima Science garden City, Hyogo 678-1297, Japan.
2 To whom correspondence should be addressed. Fax: 181-564-
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32mad (for C. elegans small and Drosophila mad) proteins, a
amily of receptor substrates. According to this model, the
inding of secreted ligands to the type-II receptor promotes
he formation of a heteromeric complex with a ligand-
pecific type-I receptor. The type-II receptor then phosphor-
lates a cytoplasmic domain, the GS domain (a glycine- and
erine-rich stretch of residues), of the type-I receptor, result-
ng in the activation of the type-I receptor. The activated
ype-I receptor of the heteromeric receptor complex then
ransduces the signal from the ligand to the downstream
mad proteins, which act as cytoplasmic mediators, by
hosphorylation. Upon phosphorylation, the heteromeric
omplex containing the Smads is activated and translocates
nto the nucleus where the Smads control the transcription
f specific target genes.
In the nematode C. elegans, four ligand proteins have
een identified as members of the TGF-b superfamily, and
wo TGF-b-like pathways have been extensively character-
ized (reviewed in Patterson and Padgett, 2000). UNC-129, a
TGF-b family member in C. elegans is required for the
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33DBL-1 Signaling in the Hypodermis for Body Length Controlexpression of the dorso-ventral polarity information that is
essential for axon guidance and guided cell migration (Co-
lavita et al., 1998), although the mechanism of cellular
migration guidance by UNC-129 and the downstream com-
ponents involved in UNC-129 signaling remain to be elu-
cidated. Another member of the TGF-b family in C. el-
egans, DAF-7 (Ren et al., 1996), is involved in the Daf (for
dauer larvae formation) pathway, the most well-
characterised TGF-b-like pathway in this organism (Thom-
as et al., 1993). Dauer larvae is the nonfeeding and devel-
opmentally arrested stage that is specialized for dispersal
characteristics that promote survival in an unfavorable
environment (Cassada and Russell, 1975). The dauer/
nondauer developmental decision is influenced by tempera-
ture and the availability of food relative to the population
density, as indicated by the concentration of a constitu-
tively secreted dauer-inducing pheromone (Golden and
Riddle, 1982, 1984a,b). The Daf pathway is a part of the
pathway regulating entry into and recovery from the dauer
larval stage in response to environmental cues (Ren et al.,
1996) and is also involved in egg-laying (Thomas et al.,
1993). The DAF-7 signaling is transduced through DAF-4
(Estevez et al., 1993; Inoue and Thomas, 2000), the only
type-II receptor kinase identified in the C. elegans genome
(C. elegans Sequencing Consortium, 1998). Mutations of
daf-4 induce small body size (Sma) and male tail abnormal
(Mab) defects in addition to phenotypes indicating muta-
tion of the Daf pathway, Daf-c (constitutive dauer forma-
tion), and Egl (egg-laying defect). These phenotypes indicate
that DAF-4 also functions in another well-characterized
TGF-b-like pathway in C. elegans, the Sma/Mab pathway.
The Sma/Mab pathway is initiated by a recently identi-
ed third member of the TGF-b family in C. elegans, DBL-1
(for Dpp, BMP-like), and regulates body size, mail tail
patterning, and the patterning of dopaminergic neurons
(Lints and Emmons, 1999; Morita et al., 1999; Suzuki et al.,
1999). DBL-1 signaling is also received and transduced
through DAF-4. The type-I receptor kinase, SMA-6 (Krishna
et al., 1999), and three Smad proteins, SMA-2, SMA-3, and
SMA-4 (Savage et al., 1996; Savage-Dunn et al., 2000), relay
the signals. Mutations of these components all result in the
Sma and Mab phenotypes. Among the components of the
two TGF-b-like pathways, DAF-4 is the only one that,
when mutated, produces both the Daf and Sma phenotypes,
and is required for both pathways. Enhancement of the
Daf-c phenotype, however, is observed in the double mu-
tant strains daf-1; sma-6 (Krishna et al., 1999) and daf-7;
cet-1 (dbl-1) (Morita et al., 1999). These observations sug-
gest that there is a low level of cross-talk between the Sma
and Daf pathways at the level of ligand–receptor interac-
tion. When green fluorescent protein (GFP) is expressed
under the control of the daf-4 promoter (Gunther et al.,
2000) or as a daf-4::gfp translational fusion gene (Patterson
et al., 1997), GFP fluorescence is found in a subset of
neurons that overlaps with GFP expression driven by thedaf-1 (type-I receptor; Georgi et al., 1990; Gunther et al.,
2000) promoter. In contrast, in the pharynx, intestine,
hypodermis, and body-wall muscles, the daf-4 promoter is
active, but the daf-1 promoter is not (Gunther et al., 2000).
This wide expression of DAF-4 is consistent with the
hypothesis that it is required for pathways in addition to the
Daf pathway. Assays using lacZ reporter fusion constructs
suggested that the type-I receptor SMA-6 and one of the
SMAD proteins, SMA-3, which are components of the
Sma/Mab pathway, are also expressed in the intestine,
pharynx, and other tissues (Krishna et al., 1999; Savage-
Dunn et al., 2000). In contrast, the expression patterns of
the dbl-1::gfp reporter fusion product showed dbl-1 expres-
ion to be restricted primarily to neurons, including the
entral nerve cord (Morita et al., 1999; Suzuki et al., 1999).
Thus, it seems likely that DBL-1 is secreted from neurons,
then acts as a signal to other cell types in targeted tissues,
which express downstream components. The cell types that
respond to the DBL-1 signal to regulate body size have not
yet been clarified.
We are interested in the mechanisms by which the ligand
DBL-1 regulates the body length of C. elegans. Here, we
examined the site of action of SMA-6 in the regulation of
body length. We show that sma-6 is highly expressed in the
hypodermis and that this hypodermal expression is neces-
sary and sufficient for the regulation of body length. We also
examined the contribution of the GATA sequences that are
present in the immediate upstream region of sma-6 ATG to
hypodermal expression.
MATERIALS AND METHODS
C. elegans Strains and General Methods
C. elegans strains were cultured and manipulated by using
standard methods (Brenner, 1974). All strains were grown at 20°C
unless otherwise noted. Strains used in this study were the wild-
type C. elegans variety Bristol N2 strain and the sma-6 mutant
train LT186 [sma-6 (wk7) II] (Krishna et al., 1999). All strains were
rovided by the Caenorhabditis Genetics Center.
Germ Line Transformation of C. elegans
Transformation of C. elegans was performed by microinjection
of plasmid DNA into the distal arms of the hermaphrodite gonad as
described previously (Mello et al., 1991). Each plasmid was pre-
pared for microinjection using the QIAGEN plasmid purification
kit (QIAGEN). All microinjections were performed at a final DNA
concentration of 100 ng/ml.
Stable transgenic lines were generated through the selection of
transformed progeny exhibiting GFP expression. For the rescue
experiment, rescue of the body-length defect was assessed. Each
transformation result was examined with multiple independent
transgenic lines.
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34 Yoshida et al.FIG. 1. sma-6<gfp is expressed in hypodermal cells. Confocal images of transgenic animals of an integrated line bearing Psma-6(23085)::gfp,
transcriptional gfp fusion construct with 3085 bp of the sma-6 59 upstream region, are shown. (Details of the construct are given in
aterials and Methods. See also Fig. 4A.) The construct includes the nuclear localization signal, but fluorescence can also be detected in
he cytoplasm. Bar, 10 mm (A–C, E–K), 50 mm (D), 100 mm (L). (A) Transmitted light image of a 1.5-fold-stage embryo. (B, C) Fluorescence
mages of the same embryo as in (A), midline plane and lateral plane of focus, respectively. Fluorescence is observed in dorsal and ventral
ypodermal cells. (D) L3 larva. Fluorescence is observed in the pharynx, intestine, and hypodermis. (E–I) Images of each part of the same
arva as in (D), at higher magnification. (E, F) Middle trunk region, midline plane, and left lateral plane of focus, respectively. Fluorescence
s observed in the intestine (E) and main body hypodermal syncytium surrounding the seam cells (V cells), which appear as dark ovals (F).
G, H) Anterior of the same larva as in (D), midline plane and left lateral plane of focus, respectively. Fluorescence is observed in the pharynx
E) and hypodermal syncytium in the head but not in H cells (seam cells in the head) (H) or V cells as in (F). (I) Fluorescence is observed in
he posterior gut and immediately posterior to the gut. (J, K) The most posterior end of a young adult worm, fluorescence and transmitted
ight images, respectively. Fluorescence is not observed in the most posterior part of the hypodermis. (L) The expression patterns of GFP
n the pharynx, intestine, and hypodermis are maintained in the adult worm.
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35DBL-1 Signaling in the Hypodermis for Body Length ControlTransformation Constructs
All GFP reporter vectors and expression vectors were obtained
from A. Fire (A. Fire, personal communication).
To generate the rescue construct pSQA13, a 9.2-kb fragment that
was cut from the cosmid clone C32D5 with PstI and Eco52I and
encompassed the sma-6 region was subcloned into pBluescript
SK(2), which was digested with PstI and NotI. A 6.0-kb BsmI to SacII
region of pSQA13 was replaced with a 2-kb BsmI to SacII fragment
from the sma-6 cDNA clone (obtained from R. Padgett). In the
esulting construct, named pSQF8, the coding region and 39 UTR of
he sma-6 cDNA clone was substituted for the corresponding regions
of pSQA13. To make the sma-6::gfp fusion construct, the 39 end of the
sma-6 coding region was amplified by using polymerase chain reac-
tion (PCR). The primers used were 14282F (“F” suffix indicates
forward direction primers), 59-GTGTGTTGTATCGCTGATT
TGGG-39, and 15129R (“R” suffix indicates reverse direction prim-
ers), 59-CGGGATCCAGATTGATTGGTGGCTGACTC-39. The
15129R primer was designed to contain a BamHI site (underlined),
instead of a TAA stop codon. Amplified fragments from the sma-6
cDNA clone or the cosmid clone C32D5 were digested with HpaI and
BamHI, then cloned in-frame between the HincII and BamHI sites of
the GFP reporter vector pPD95.77 and named pQG5.1H4 and
pQG1.0B1, respectively. A PstI to HpaI fragment, 4.5 kb from pSQF8
or 5.2 kb from pSQA13, containing upstream regulatory sequences
and another part of the coding region of sma-6, was inserted between
the PstI and HincII sites of pQG5.1H4 or pQG1.0B1 and named
pQG5.2I19 (Psma-6(23085)::sma-6) and pQG1.1C1, respectively. To gener-
te pGFP4G31, a transcriptional GFP reporter construct, 1.3-kb frag-
ents containing the 59 upstream sequence and the initiator methi-
nine codon of SMA-6 were amplified by using PCR from the sma-6
enomic clone pSQA13. The amplified products were digested with
alI and BamHI and the resulting 0.85-kb fragments were inserted
nto the GFP reporter vector pPD95.67 digested with SalI and BamHI.
he primers used were: 11146F, 59-CGCTTTTTGAAGCTTT
GGC-3 9 ; and 12478R, 5 9 -CGGGATCCATTAAATC
FIG. 2. Hypodermal SMA-6 can elongate the reduced body length
of the sma-6 mutant. (A) Schematic diagram of the constructs used
and summary of the results. (B) sma-6 (wk7). (C) Wild-type N2.
(D–I) Transgenic animals bearing an extrachromosomal array ex-
pressing SMA-6 in pharyngeal muscle (D, Pmyo-2::sma-6), intestine
E, Pyk92e8::sma-6), hypodermis (F and G, Pdpy-7::sma-6), and neurons
H and I, Pdbl-1::sma-6) in a sma-6 (wk7) mutant background. GFP
as fused to the C-terminal end of SMA-6, but fluorescence was
xtremely weak and sometimes was not detectable in these cases.
he fluorescence observed in (D), (E), and (I) is due to a transcrip-
ional gfp reporter construct with each promoter coinjected with
he sma-6 cDNA construct to reconfirm the promoter activity. (G)
luorescence image of a L3 larvae of Pdpy-7::sma-6 transgenic line.
he fluorescence observed in the hypodermis is also due to a
ranscriptional gfp reporter Pdpy-7::gfp and the fluorescence in the
pharynx is due to other Pmyo-2::gfp. Because of very weak expres-
sion of Pdpy-7::gfp, the reporter gene Pmyo-2::gfp was coinjected as
another marker. (I) Fluorescence image of the same animal as in
(H). The Pdpy-7::sma-6 array rescued the Sma phenotype, but the
myo-2::sma-6, Pyk92e8::sma-6, and Pdbl-1::sma-6 arrays did not. Bar, 100
mm.
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36 Yoshida et al.TGAAATTTGC-39. The 12478R primer was designed to contain a
BamHI site (underlined) following the ATG start codon.
A 2.2-kb PstI to SalI fragment, further upstream from the SalI
site, was excised from pQG1.1C1 and inserted into pGFP4G31,
which was digested with PstI and SalI. The resulting GFP reporter
onstruct contained a 3-kb sma-6 59 upstream region, and was
designated pGFP4J1 (Psma-6(23085)::gfp). p414GFP (Psma-6(2414)::gfp), a
GFP reporter construct containing 414 bp of sma-6 59 upstream
sequence, was created by a deletion spanning from the PstI site to
the DraIII site of pGFP4J1. p414Q (Psma-6(2414)::sma-6), which con-
ained the same regulatory region as p414GFP and the sma-6::gfp
usion gene, was also made by deleting the PstI to DraIII region
rom pQG5.2I19.
A series of further deletion constructs from 2414 (the number
ndicates the bp relative to the ATG) were made by using the PCR
ethod with forward primers together with the reverse primer,
2478R. The sequences of the forward primers used were as follows,
ith the number of each referring to its position relative to ATG:
308F, 59-AACTGCAGCCGCACTTCTACCTATTCTCCG-39;
2284F, 59-AACTGCAGTCATACATATATCCATTTTGGC-39;
2277F, 59-AACTGCAGTATATCCATTTTGGCGCAAC-39;
2265F, 59-AACTGCAGGGCGCAACTTTTCCGTTCAG-39;
2248F, 59-AACTGCAGCAGATCATTAGTATCATTAGG-39;
2234F, 59-AACTGCAGCATTAGGCGGACAAGTTGTC-39;
2219F, 59-AACTGCAGTTGTCAAAAAGAACATTAAGTG-39;
2209F, 59-AACTGCAGGAACATTAAGTGAATGATGAG-39;
2157F, 59-AACTGCAGAGGCCGTAGATTGAAATATTG-39.
These forward primers contained a PstI site (underlined), while the
reverse primer 12478R contained a BamHI site, allowing the am-
plified fragments to be inserted into pPD95.67 digested with PstI
and BamHI. The resulting GFP reporter constructs were designated
according to the position of their 59 end relative to the ATG.
pDGATA-GFP (Psma-6(DGATA)<gfp) was generated by using the PCR
ethod with p414GFP as the DNA template. The sequences of
rimers used were as follows: 2157F, 59-AACTGCAGAGGCC-
GTAGATTGAAATATTG-39; 2194R, 59-GCTCTAGACATTC-
ACTTAATGTTC-39. Forward primer 2157F contained a PstI site,
while reverse primer 2194R contained a XbaI site (underlined). The
resulting construct contained 414 bp with an internal deletion of three
GATA elements of the sma-6 59 upstream sequence. The same
primers and p414Q as the template DNA were used to create
pDGATAQ (Psma-6(DGATA)::sma-6), which had the same upstream se-
uence as pDGATA-GFP and the sma-6::gfp fusion gene.
Mutation of each of three GATA elements located between 2190
nd 2161 bp was performed by using PCR with a mutant primer and
414GFP or p414Q as the DNA templates. The sequences of the
rimers used were as follows: Mutant GATA 1 F, Forward primer for
utant GATA 1, 59-CTCGCTTTAAGAGAGATAGTGTACTG-
TAG-39 annealing to positions 2190 to 2161; 2191R, Reverse
rimer for mutant GATA 1, 59-CATCATTCACTTAATGTTC-
TTTTGAC-39, complementary to positions 2217 to 2191; Mutant
ATA 2 F, Forward primer for mutant GATA 2, 59-
TCGCTTGTACTGATAGAAGAGGCCGTAG-39, positions 2177
o 2149; 2178R, Reverse primer for mutant GATA 2, 59-CTCTT
ACTATCTCATCATTCAC-39, complementary to positions 2200
o 2178; 2160F, Forward primer for mutant GATA 3, 59-
AGAGGCCGTAGATTGAAATATTGTACG-39, positions 2160 to
133; Mutant GATA 3 R, Reverse primer for mutant GATA 3,
9-AGCGACGTACACTATCTCTCTTAACTATC-39, complemen-
ary to positions 2189 to 2161. Substituted nucleotides in the GATAonsensus sequences are indicated in bold. All mutations were veri-
ed by DNA sequencing.
Transformation Constructs for Tissue-Specific
Expression
The sma-6 cDNA clone was subcloned into the heat shock
romoter vector pPD49.83 by using the KpnI and SacI site, then the
paI to SpeI fragment of pQG5.2I19 was subcloned into it. The
esulting construct, designated pQGL11, contained a sma-6::gfp
usion gene driven by the hsp16.41 promoter (Phsp16.41::sma-6).
Replacing the heat shock promoter with a myo-2 promoter made
the pharyngeal muscle-specific expression construct, Pmyo-2::sma-6.
he myo-2 promoter was obtained from the expression vector
pPD30.69 using the NheI and SpeI sites. The 4-kb 59 upstream
sequence of dbl-1 (Morita et al., 1999) was used for a neuron-
pecific expression construct, Pdbl-1::sma-6. The 0.6-kb 59 upstream
equences of Y105C5A.13 or dpy-7 (Gilleard et al., 1997; Johnstone
nd Barry, 1996) were used for intestine- or hypodermis-specific
xpression constructs, Pyk92e8::sma-6 and Pdpy-7::sma-6, respectively.
The cDNA clone yk92e8 was originally obtained as a gene that was
own-regulated by DBL-1 signaling (Mochii et al., 1999) and was
ncoded by Y105C5A.13. The promoter region of Y105C5A.13 had
ut-specific activity. Each promoter region was amplified by using
CR from the genomic DNA and digested with PstI and XbaI. The
equences of the primers used were as follows: 92e8-642F,
9-AACTGCAGTGGCAAGTAGGAGGGAGG-39; 92e8-3R,
59-GCTCTAGATTCACGGAGTTGATAGGC-39; dpy-7-603F,
59-AACTGCAGTGAGTGTTCGAGCTCCAACC-39; dpy-7-R,
59-GCTCTAGATTTATCTGGAACAAAATGTAAG-39. These for-
ward primers (F) contained a PstI site (underlined), while reverse
primers (R) contained a BamHI site. The amplified and digested
fragments were inserted into the GFP reporter vector pPD95.69 or
substituted for the heat shock promoter of pQGL11. The 0.8-kb 59
pstream sequence of rol-6 (Mello et al., 1991) from pRF4 was also
used for a hypodermis-specific expression construct, Prol-6::sma-6,
and the 2.2-kb of mtl-2 promoter from the expression vector
pPD54.01 was used for the other intestine-specific expression con-
struct, Pmtl-2::sma-6.
Worm Body-Length Measurement
Animals were grown at 20°C. Adult hermaphrodites were spread
on seeded plates and allowed to lay eggs for several hours. The
adults were then removed and the embryos were allowed to hatch
and develop. For Pmtl-2::sma-6 transgenic line, animals were grown
on the plates supplemented with 10 mM CdCl2 for induction. We
confirmed the induction at the 10-mM concentration by using a
ranscriptional reporter Pmtl-2::gfp (data not shown). Six days after
hatching, F1 adults were transferred to a fresh plate and anesthe-
ized with 200 ml of 10 mM sodium azide solution. Anesthetized
nimals were linearized and their body lengths were measured by
sing a dissecting microscope and micrometer.
RESULTS
sma-6 Is Expressed in Hypodermal Cells
In contrast to DAF-4, whose mutation affects dauer
larvae formation (Daf), body length (Sma), and male-specific
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37DBL-1 Signaling in the Hypodermis for Body Length Controlstructures (Mab) (Baird and Ellazar, 1999; Flemming et al.,
2000; Riddle et al., 1981; Suzuki et al., 1999), sma-6
mutants display only the Sma and Mab phenotypes (Jiang
and Sternberg, 1999; Krishna et al., 1999). Therefore, SMA-6
s considered to be involved exclusively in the regulation of
ody length and establishes the specificity of this TGF-b
pathway (Krishna et al., 1999). To reveal how the ligand
bl-1, which is mainly expressed in neuronal cells such as
he ventral nerve cord and AFD neurons (Morita et al.,
999; Suzuki et al., 1999), acts on the type-I receptor SMA-6
o regulate body length, we first examined the expression
attern of sma-6 during the course of C. elegans develop-
ent. We fused 3 kb of the 59 promoter region of sma-6
Krishna et al., 1999) with GFP to create a transcriptional
eporter gene (see Fig. 4A) and monitored sma-6 expression
n transgenic worms. The worms harboring the GFP re-
orter gene were fluorescent throughout the pharyngeal
uscle, intestine, and hypodermis. The fluorescence was
bserved from around the 1.5-fold stage (Figs. 1A–1C) and
ontinued to the adult stage (Figs. 1D and 1L). The expres-
ion in the hypodermis was detected in the dorsal (hyp-7)
nd ventral hypodermal cells (P cells) in the main body
egion (Figs. 1B–1J), but not in the lateral hypodermal H, V,
nd T cells (seam cells) (Figs. 1D, 1F, and 1H). The expres-
ion was also detected in a part of the hypodermal cells of
he head (hyp-6) (Figs. 1G and 1H), but not in the hypoder-
al cells of the anterior (hyp-1, -2, -3) and posterior end
hyp-10) (Figs. 1G and 1J).
Our previous report using in situ hybridization of sma-6
ndicated expression only in the head region and intestine
rom L2 larva to the young adult stage (Mochii et al., 1999).
nd, using a lacZ reporter, Krishna et al. (1999) reported
hat sma-6 was also expressed during the embryonic stage
s well as in the larval and adult stages and in the intestinal
ells and pharyngeal muscle. In addition to this expression,
ur present study using the GFP reporter demonstrates that
TABLE 1
Hypodermis-Specific Expression of sma-6 Can Elongate the Reduc
Genotype Transgene
Wild-type N2 None
dbl-1 (nk3) None
sma-6 (wk7) None
sma-6 (wk7) nkEx156[Pmyo-2::sma-6]
sma-6 (wk7) nkEx172[Pyk92e8::sma-6]
sma-6 (wk7) nkEx188[Pmtl-2::sma-6]
sma-6 (wk7) nkEx164[Pdpy-7::sma-6]
sma-6 (wk7) nkEx176[Pdpy-7::sma-6]
sma-6 (wk7) nkEx191[Prol-6::sma-6]
sma-6 (wk7) nkEx193[Prol-6::sma-6]
a Data are presented by mean 6 SD. Body lengths were determin
b Number of animals measured.ma-6 is also expressed in the hypodermis from the midem-ryonic stage to adult. The subtle discrepancy is probably
ue to a difference in the sensitivity of each method. This is
specially true regarding hypodermal expression because
he expression is weak compared to that in pharynx and
ntestine.
Unlike the expression of dbl-1, as revealed by the dbl-1::
fp reporter gene (Morita et al., 1999; Suzuki et al., 1999;
ee also Fig. 2I), we did not observe the expression of the
FP reporter with the sma-6 promoter in the nervous
ystem. This suggests that DBL-1 expressed in neurons is
ecreted and directed by an unknown mechanism to the
MA-6 expression site to activate SMA-6/DAF-4 signaling.
his apparent long-range action, which was predicted by
he expression profiles of dbl-1 and sma-6, prompted us to
etermine which site of SMA-6 expression was required for
ody-length regulation.
Hypodermal Expression Is Sufficient for Restoring
Body Length
The Sma phenotype of sma-6 was rescued by either the
transgenesis of cosmid C32D5 containing the entire sma-6
coding region (data not shown; see Krishna et al., 1999) or a
sma-6 cDNA with the promoter region described above (see
Figs. 4A–4C and Table 2). To examine the site of SMA-6
expression that was required for body-length regulation,
i.e., the target tissue for DBL-1, we attempted to rescue the
Sma phenotype of a null mutant of sma-6 (wk7) by gener-
ating transgenic worms carrying the sma-6 cDNA driven by
different tissue-specific promoters.
We first generated a translational sma-6::gfp fusion con-
struct and examined its ability to rescue the sma-6 pheno-
type. When GFP was fused to the C-terminal end of SMA-6,
the resulting product rescued the Sma phenotype (see Fig.
4), suggesting that the SMA-6::GFP was functional as a
SMA-6 type-I receptor. The fluorescence of the GFP was
dy Size of sma-6 Mutant
ength (mm)a Width (310 mm)a nb
1.33 6 0.15 0.71 6 0.04 43
0.98 6 0.06 0.71 6 0.03 58
1.02 6 0.06 0.69 6 0.03 43
1.01 6 0.10 0.72 6 0.04 84
0.99 6 0.07 0.71 6 0.04 86
0.96 6 0.05 0.70 6 0.04 33
1.36 6 0.09 N.D. 54
1.46 6 0.09 0.62 6 0.04 61
1.17 6 0.08 0.62 6 0.06 46
1.39 6 0.29 0.68 6 0.06 70
or each adult hermaphrodite at 6 days after hatched.ed Bo
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38 Yoshida et al.cases. Thus, to trace the region of expression, a GFP
reporter gene fused only with each tissue-specific promoter
was always coinjected with the rescuing construct
(sma-6::gfp), which was fused with the same promoter. This
enabled detectable fluorescence to be monitored to ensure
tissue-specific activity of the promoter.
The dpy-7 promoter (Pdpy-7) and rol-6 promoter (Prol-6) were
sed for the hypodermal-specific expression of sma-6. dpy-7
nd rol-6 are the cuticle collagen genes that are expressed
pecifically in the hypodermis (Gilleard et al., 1997; Kramer
nd Johnson, 1993; Fig. 2G). For pharyngeal muscle-specific
FIG. 3. Effect of deletions of the 59 upstream region of sma-6 on gf
constructs used and summary of the results. All fragments were su
fusions. Numbers refer to the 59 end position of the fragments r
recognition sequence of GATA-type transcription factors. The ve
observed in the cytoplasm. (B–E) Confocal images of the middle tru
array of a deletion construct. The numbers correspond to the 59 end
f focus of an animal, respectively. The intensity of fluorescenc
xpression in the intestine remains in spite of the deletion to 2209
277 bp sometimes led to ectopic GFP expression in the body waxpression, Pmyo-2 , the promoter region of myo-2, whichcodes for pharyngeal muscle-specific myosin (Okkema et
al., 1993; Fig. 2D), was used. Pyk92e8 , the promoter region for
predicted gene, Y105C5A.13, which encodes yk92e8, was
sed for gut-specific expression. yk92e8 is one of the cDNA
lones previously identified as a down-regulated gene in
ma-2 mutants in a cDNA microarray experiment (Mochii
t al., 1999). The expression pattern of the GFP reporter
ene with Pyk92e8 suggested that the activity of the promoter
is intestine-specific (Fig. 2E), and the expression was de-
tected through all the developmental stages from the late
embryonic stage (data not shown). The promoter of mtl-2, a
ression in hypodermal cells. (A) Schematic diagram of the deletion
ned into the gfp reporter vector pPD95.67 to create transcriptional
ve to the A of ATG, as 11. Clear ovals indicate the consensus
includes a nuclear localization signal but fluorescence was also
egion of transgenic animals (L2–L3) bearing an extrachromosomal
dicated in (A). Bar, 10 mm. (B, C) Midline plane and left lateral plane
the hypodermis is weakened according to deletions (B, D). GFP
, E), but hypodermal expression has disappeared (E). Deletions from
scle (see D, arrowhead) and some neurons (not shown).p exp
bclo
elati
ctor
nk r
as in
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bp (Cmetallothionein gene expressed exclusively in intestinal
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39DBL-1 Signaling in the Hypodermis for Body Length Controlcells upon cadmium induction, was also used as an
intestine-specific promoter (Freedman et al., 1993; Moil-
anen et al., 1999). Phsp16.41 , the promoter for a heat shock
ene hsp16.41, and Psma-6(23085) , the promoter region of sma-6,
ere also used for ubiquitous expression and for authentic
ma-6 expression, respectively.
The results are summarized in Table 1 and Fig. 2. Only
ypodermal expression of SMA-6 with the dpy-7 and rol-6
promoters and ubiquitous expression with the hsp16.41
promoter (data not shown) elongated the shortened body
length of the sma-6 mutant (Table 1 and Figs. 2A and 2F).
Neither intestine nor pharyngeal muscle expression res-
cued the Sma phenotype (Table 1 and Figs. 2A, 2D, and 2E).
Further, we also examined whether the expression of
SMA-6 in neurons rescued the shortened body length by
driving sma-6 with a dbl-1 promoter (Pdbl-1). Neuronal
expression did not rescue the phenotype (Table 1 and Figs.
2A, 2H, and 2I). This results suggests that the Sma pathway
is not active in neurons secreting DBL-1 and the ligand
functions non-cell-autonomously to regulate body length.
Finally, these results indicate that the hypodermal expres-
sion of SMA-6 is sufficient and thus the hypodermis is the
key tissue for the regulation of body length. In addition to
body length, we also tested the change of body width of
each transgenic animal (Table 1). Although there was a
slight decrease in the width of gravid adult animals of
Pdpy-7::sma-6 and Prol-6::sma-6 transgenic lines, hypodermal
MA-6 increased the body length more than the body
idth.
Minimum Sequence Required for Hypodermal
Expression of sma-6
Because the backbone of the constructs using sma-6
cDNA)::gfp for the rescue experiments was the GFP vector
obtained from A. Fire), the original 39 UTR of the sma-6
ene was removed and replaced by that of the vector (for
etails, see Materials and Methods). From the above obser-
ations, we assumed that the sequences in either the
ntrons or the 39 UTR of the sma-6 gene are dispensable and
hat the cis element that drives the hypodermis-specific
xpression of SMA-6 must exist in the 59 promoter region.
herefore, we prepared stepwise deletions of the 59 up-
tream region of the sma-6 promoter to identify the mini-
um element that was sufficient for its hypodermis-
pecific expression.
Deletion to 2414 bp (relative to the initiator ATG) did
ot affect hypodermal, intestinal, or pharyngeal expression
see Figs. 4A, 4D, and 4E). The expression level revealed by
or ability to rescue the Sma phenotype. (F, G) Psma-6(DGATAx3)::sma-6.
fp reporter expression persists in the pharynx and intestine but is
ot observed in the hypodermis, even at a higher magnification.FIG. 4. Internal deletion of putative GATA recognition sequences
from the sma-6 promoter removes the hypodermal expression and
bility to rescue the Sma phenotype. (A) Schematic diagram of the
onstructs used and summary of the results. The numbers indicate
he 59 end of the upstream region contained in each construct,
elative to ATG. The internal deletion of the three GATA recog-
ition sequences is referred to as D(GATAx3). (B–G) Transgenic
ma-6 (wk7) animals bearing an extrachromosomal array express-
ng sma-6 cDNA from each 59 upstream sequence shown in (A). A
fp reporter construct with each promoter was coinjected for the
ame reason as in Fig. 2. The left panels (C, E, G) show confocal
mages of the middle trunk region of the same 6-day-old adult
orms as in the right panels (B, D, F), at a higher magnification and
ith a midline plane focus. Bar, 100 mm (B, D, F), 50 mm (C, E, G).
(B, C) Psma-6(23085)::sma-6 was used as a control. (D, E)
here was no rescue of the reduced body length.
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40 Yoshida et al.GFP in the hypodermis decreased gradually with further
deletion, from 2284 to 2219 bp, but the promoter was still
ctive in the tissue to a certain extent. The expression of
FP in the pharynx and intestine was also retained (Fig. 3).
eletion to 2209 bp resulted in the disappearance of
ypodermal expression but not of pharyngeal or intestinal
xpression (Fig. 3E). Thus, sequences between 2219 and
209 bp appeared to be necessary for the hypodermal cell
xpression, but no conserved cis elements could be identi-
ed in this region. Instead, immediately downstream of this
egion, we identified three typical GATA recognition se-
uences (hereafter referred to as GATA elements), WGA-
AR (Ko and Engel, 1993; Merika and Orkin, 1993;
michinski et al., 1993), in tandem within a short region,
s shown in Figs. 4A and 5A.
GATA Recognition Sequences Are Required for
Hypodermal Expression of sma-6 and the
Regulation of Body Length
We then deleted only a relatively short sequence of 30 bp
including the three consecutive GATA elements from the
truncated promoter (414 bp in length) to determine whether
deletion of the GATA elements affected the hypodermal
expression of sma-6. As we expected, the three GATA
elements were necessary for hypodermal expression of the
gfp reporter gene, but not for intestinal or pharyngeal
expression (Figs. 4A, 4F, and 4G). To test its ability to drive
SMA-6 to rescue the small phenotype of the sma-6 mutant,
these truncated 59 regulatory regions were used to express
the sma-6 cDNA. Expression with the 414-bp 59 upstream
sequence (Psma-6(2414)::sma-6) rescued the reduced body length
of the sma-6 mutants, whereas sma-6 cDNA with the
promoter that lacked the three GATA sequences
(Psma-6(DGATA)::sma-6), failed to rescue the Sma phenotype (Fig.
and Table 2).
From these observations, we expected that the three GATA
equences were necessary and sufficient for hypodermal ex-
ression of sma-6. However, 2209 bp of the sma-6 59 up-
tream sequence (relative to ATG), including the GATA
TABLE 2
Deletion of GATA Recognition Sequences from Truncated sma-6
Genotype Transgene
Wild-type N2 None
dbl-1 (nk3) None
sma-6 (wk7) None
sma-6 (wk7) nkEx112[Psma-6(23085)::sma-6]
sma-6 (wk7) nkEx127[Psma-6(2414)::sma-6]
sma-6 (wk7) nkEx180[Psma-6(DGATA)::sma-6]
a Data are presented by mean 6 SD. Body lengths were determin
b Number of animals measured.lements and about 20 bp of flanking sequence, neither tupported hypodermal expression of the gfp reporter gene
Figs. 3A and 3E) nor rescued the Sma phenotype (data not
hown). This finding suggested that the GATA sequences
ere required but not sufficient to support hypodermal ex-
ression of sma-6 and that the upstream flanking sequence
as also required. To determine the contribution of each
ATA element to hypodermal expression, we made a series of
ranscriptional reporter fusion genes with mutated promoter,
n which all or each one of the three elements were mutated.
ach mutation was designated as mutant GATA123 or mu-
ant GATA1, GATA 2, and GATA 3 starting from the 59
pstream and according to their positions, respectively (See
ig. 5A). We tested them for the ability to produce hypodermal
xpression. The introduction of the mutation in any one of the
hree GATA elements affected hypodermal, but not intestinal
nd pharyngeal, expression of gfp reporter gene (Fig. 5). When
he mutation was in the most downstream GATA element
Pmutant GATA3::gfp), however, the effect was not as striking as
hose in the other two mutations, and the transgenic animals
ested all expressed GFP in the hypodermis, even though the
xpression intensity was reduced to some degree (Figs. 5A, 5F
nd 5G). In contrast, when the function of the middle GATA
lement was ablated, the mutation (Pmutant GATA2::gfp) greatly
educed expression in the hypodermis, and in many cases
ypodermal expression disappeared (Figs. 5A, 5D, and 5E). The
utation in the first GATA element (Pmutant GATA1::gfp), which
is located most upstream of ATG, was also remarkably defec-
tive in its ability to drive hypodermal expression. Expression
from Pmutant GATA1 did not disappear completely and some ani-
mals tested had hypodermal expression but it was barely
detectable (Figs. 5A–5C). Mutant GATA2 often resulted in
ectopic expression of GFP in the body-wall muscles and
neurons (data not shown), but mutant GATA1 and mutant
GATA3 did not. These results suggests that each of the GATA
elements contributes to a different extent to drive the appro-
priate expression of sma-6 in the hypodermis. The middle
ATA element is the most important and the first one is also
ecessary for appropriate expression, but the contribution of
he third element for hypodermal expression might be mini-
al. To confirm whether these reductions of promoter activi-
oter Results in Loss of Ability to Rescue for the Sma Phenotype
Length (mm)a Width (310 mm)a nb
1.33 6 0.15 0.71 6 0.04 43
0.98 6 0.06 0.71 6 0.03 58
1.02 6 0.06 0.69 6 0.03 43
1.33 6 0.07 0.72 6 0.04 26
1.24 6 0.06 0.70 6 0.04 38
0.96 6 0.06 0.70 6 0.04 38
or each adult hermaphrodite at 6 days after hatched.Prom
ed fies in the hypodermis correlate with body-length regulation,
p
t
m
t
p
m
i
t
a
G
3
t
o
a
i
p
e
a
a
s
F
a
s
p
f
t
d
t
(
i
S
G
a
e
e
f
S
l
d
T
h
t
p
t
d
f
n
t
41DBL-1 Signaling in the Hypodermis for Body Length Controlwe also generated some transgenic lines carrying sma-6 ex-
ression constructs with these mutated promoters. Consis-
ent with the above failures of hypodermal expression, the
utations in the GATA elements 1 and 2 resulted in loss of
he ability to rescue the Sma phenotype in spite of the
resence of intestinal and pharyngeal expression. The third
utated promoter construct retained the ability reflecting the
ntactness of the activity in the hypodermis (Table 3). As in
he case of deletion of all the GATA elements (Figs. 4A, 4F,
nd 4G), triple mutation of all three GATA elements (mutant
ATA123) resulted in both loss of the ability to rescue (Table
) and hypodermal expression, but expression in the other
issues was maintained (not shown). Together with the result
f experiments using tissue specific promoters, these results
gain suggest that the Sma pathway alone in the pharynx and
ntestine cannot regulate body size and the hypodermis is the
rimary target tissue for the regulation.
DISCUSSION
How an organism’s body size or length is determined is a
fundamental question in biology. In mammals, it is widely
accepted that body size is determined by the number of
cells but not by the cell size. In nematodes, however, there
are a number of cases in which the cell numbers do not
correlate with body length (Flemming et al., 2000). We
xamined how nematode growth is regulated by focusing on
polypeptide growth factor belonging to the TGF-b super-
family and its signaling pathway in C. elegans.
We demonstrated that the type-I receptor gene sma-6 is
expressed in the hypodermis at a significant level (Fig. 1),
and confirmed its previously reported expression in the
intestine and pharynx (Krishna et al., 1999; Mochii et al.,
1999). We also identified three putative GATA transcrip-
tion factor binding sites, WGATAR (Ko and Engel, 1993;
Merika and Orkin, 1993; Omichinski et al., 1993), present
in the region immediately upstream of the sma-6 transla-
tion start site. These elements are situated in tandem in the
TABLE 3
The Reduction of Hypodermal Expression and Loss of the Ability
Genotype Transgene
Wild-type N2 None
dbl-1 (nk3) None
sma-6 (wk7) None
sma-6 (wk7) nkEx201[PmutantGATA1::sma-6]
sma-6 (wk7) nkEx205[PmutantGATA2::sma-6]
sma-6 (wk7) nkEx212[PmutantGATA3::sma-6]
sma-6 (wk7) nkEx218[PmutantGATA123::sma-6]
a Data are presented by mean 6 SD. Body lengths were determin
b Number of animals measured.forward orientation. These GATA elements are required for tthe proper expression pattern of sma-6 in the hypodermis
and the expression correlates with the ability to regulate
body length (Fig. 4, Table 2, Fig. 5, and Table 3). Multiple
GATA elements are found in the upstream region of
intestine-specific genes, vit-2, ges-1, cpr-1, mtl-2, and elt-2,
nd some of them are required for intestine-specific expres-
ion of these genes (Britton et al., 1998; Egan et al., 1995;
ukushige et al., 1999; MacMorris et al., 1992; Moilanen et
l., 1999). GATA elements also exist in the upstream
equence of dpy-7, one of the cuticle collagen genes ex-
ressed in the hypodermis, and are suggested to be required
or hypodermal expression of this gene. Furthermore, as in
he case of sma-6, deletion of the 59 upstream region of
py-7 containing the GATA consensus sequence results in
he loss of lacZ reporter expression in the hypodermis
Gilleard et al., 1997).
In the C. elegans genome, seven GATA factors have been
dentified and four others have been predicted (C. elegans
equencing Consortium, 1998). Two of the identified
ATA factors, end-1 (Zhu et al., 1997) and elt-2 (Hawkins
nd McGhee, 1995), are expressed exclusively in the
ndoderm. A requirement of end-1 and elt-2 for endoderm
specification has been demonstrated (Fukushige et al.,
1998, 1999; Zhu et al., 1997, 1998). Others, elt-1 and elt-3,
are required for development of the hypodermis. elt-1 is
xpressed during the early embryonic stages and is required
or epidermal cell fates in the embryo (Page et al., 1997;
pieth et al., 1991), and elt-3, which is expressed from the
ate embryo to adult stages, might also be required for the
evelopment of the hypodermis (Gilleard et al., 1999).
herefore, ELT-1 and ELT-3 might participate in the
ypodermis-specific regulation of sma-6 expression. Al-
hough no obvious phenotype was reported from the sup-
ression of elt-3 by RNA-i (Gilleard et al., 1999) and, also,
he RNA-i for elt-3 did not cause any defect on the hypo-
ermal expression of sma-6 (data not shown), other GATA
actors might compensate for the function of elt-3. We did
ot examine the possible genetic interaction between mu-
ants of these GATA factors and sma-6 mutants, because
scue by the Mutations in GATA Element Are Correlated
Length (mm)a Width (310 mm)a nb
1.33 6 0.15 0.71 6 0.04 43
0.98 6 0.06 0.71 6 0.03 58
1.02 6 0.06 0.69 6 0.03 43
1.03 6 0.06 0.71 6 0.04 46
1.05 6 0.06 0.72 6 0.04 40
1.27 6 0.10 0.71 6 0.06 81
1.03 6 0.06 0.70 6 0.04 52
or each adult hermaphrodite at 6 days after hatched.to Re
ed fhe elt-1 mutation in particular is embryonically lethal
ee
D
e
o
fl
42 Yoshida et al.(Page et al., 1997); however, it is very likely that the
expression of sma-6 is regulated by such GATA factors
xpressed in the hypodermis.
Our results suggest that sequences adjacent to the GATA
lements are also essential for hypodermal expression.
eletion of a sequence immediately upstream of the GATA
lements dramatically reduced the transcriptional activity
f the sma-6 promoter in the hypodermis. Deletion of the 59
flanking sequence from 2265 bp (relative to ATG) as well as
Pmutant GATA2::gfp sometimes resulted in ectopic expression of
the GFP reporter in part of the body wall muscle and in
FIG. 5. Analysis of effect of mutations in the putative GATA re
within 414 bp of the 59 upstream region of sma-6 was mutated ind
of the results. Clear ovals indicate the putative GATA recognition
the sequence are locations relative to the A of ATG. The vector in
in the cytoplasm. Mutated promoters are referred to as Pmutant G
to 39 side, respectively. (B–G) Transgenic L2–L3 animals bearing
promoter. The left panels show confocal images of the middle trun
magnification and focus on the left lateral (C, G) or midline (E) plan
weak fluorescence can be observed in the main body hypodermal
uorescence is observed in the hypodermis even at a higher magni
cell areas surrounded by intensely fluorescent hypodermal syncytiu
the gfp reporter gene in the pharynx and intestine is maintained.some neurons (Fig. 3D). These results suggest that theflanking sequence is important for the hypodermal-specific
expression. Requirement of the sequence upstream of the
three GATA elements for hypodermal expression suggests
that other transcription factors act with the GATA factor at
the site, although no known transcription factor binding
sequence has been identified there. Several studies in ver-
tebrates and Drosophila demonstrated that other transcrip-
tion factors and cofactors interact with GATA factors
(reviewed in Charron and Nemer, 1999; Molkentin, 2000).
Some of these interactions are required for full activation of
transcription, and tissue- or developmentally restricted
ition sites on hypodermal expression. Each of three GATA sites
ally. (A) Schematic diagram of the constructs used and summary
and the mutated sites are represented by an “X.” The numbers on
s a nuclear localization signal but fluorescence was also observed
1, 2, and 3, according to the position of the GATA site from the 59
xtrachromosomal array of gfp reporter fusion with the mutated
ion of the same animals as in the right panels (B, D, F), at a higher
r, 50 mm (B, D, F), 10 mm (C, E, G). (B, C) Pmutant GATA1::gfp. Extremely
cytium only at a higher magnification. (D, E) Pmutant GATA2::gfp. No
on. (F, G) Pmutant GATA3::gfp. The clear expression pattern, dark seam
s evident even at lower magnification. In either case, expression ofcogn
ividu
sites,
clude
ATA
an e
k reg
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m, ifactors might fulfill the role of conferring specificity to
G43DBL-1 Signaling in the Hypodermis for Body Length ControlGATA-type transcription factors (Durocher et al., 1997;
ong and Dean, 1993; Kawana et al., 1995; Merika and
Orkin, 1995).
While the DBL-1 ligand is expressed mainly in some
neurons (Morita et al., 1999; Suzuki et al., 1999), the type-II
receptor DAF-4 is expressed rather broadly in the hypoder-
mis, intestine, and pharynx, in addition to the nervous
system (Gunther et al., 2000; Patterson et al., 1997). The
expression pattern of sma-3, which codes for one of the
three SMAD proteins that function downstream of SMA-6
in the Sma pathway, overlaps with that of sma-6 (Krishna et
al., 1999; Savage-Dunn et al., 2000). Thus, the hypodermis,
pharynx, and gut, where both type-I and type-II receptors for
Sma signaling are expressed, are expected to be good candi-
dates for target tissues of DBL-1. If this is the case, the
ligand might be secreted and act nonautonomously on these
target cells, which express a set of downstream molecular
components for body-length regulation. It is noteworthy
that DBL-1 signaling itself regulates sma-6 expression after
the initiation of sma-6 gene expression, thereby constitut-
ing an autoregulatory circuit (Mochii et al., 1999).
In the present study, expression of sma-6 in neurons
secreting DBL-1 does not contribute to regulate body
length. The hypodermis is the most important target tissue
for regulation of body length by region-specific expression
of a functional SMA-6 fusion protein and by the rescue of
the Sma phenotype of the sma-6 mutant. The hypodermis is
a group of cells underlying the cuticle, most of which are
multinucleated syncytia (Hedgecock and White, 1985; Sul-
ston and Horvitz, 1977). In particular, hyp-7 is the largest
hypodermal cell and covers a large part of the body. We
observed a high level of sma-6 expression in hyp-7, which
suggests that hyp-7 contributes largely to the regulation of
body length. Hypodermal cells also define the change of
shape from an oval to a worm shape during embryogenesis
(reviewed in Simske and Hardin, 2001). Recently, in our
efforts to investigate the molecular mechanisms of body-
length regulation, we identified a target gene that is nor-
mally suppressed by DBL-1 signaling and is also expressed
in the hypodermis. Overexpression of this gene in the
hypodermis but not in the intestine shortens body length
(K.M. et al., unpublished data). Taken together, the results
indicate that the hypodermis is a key tissue involved in
determining body length.
Although, in contrast to our results, Inoue and Thomas
(2000) reported that hypodermal expression of daf-4 using
the rol-6 promoter could only partially rescue the small
body size of daf-4 mutants, the difference might be due to a
difference in the expression level in different transgenic
lines. Indeed, our transgenic lines carrying Prol-6::sma-6
seem to differ somewhat in the extent of body-length
elongation depending on the line (Table 1). Alternatively,
the difference between these results might be due to a
difference in the conditions of growth and measurement of
size. They maintained animals at 15°C to prevent dauerlarva formation and measured them at the young adult
stage, while we maintained them at 25°C and measured
them when they were adults (6 days after hatching).
Additionally, they also reported that expression of daf-4
in other tissues was involved in body-size regulation. Espe-
cially, they demonstrated that pharyngeal expression of
daf-4 participates in the regulation of worm body width and
length. Therefore, we also measured the body width of all
transgenic lines. The width of the worm, which was ex-
tended by hypodermis-specific expression of sma-6 using
the dpy-7 or rol-6 promoters, was slightly less than that of
the wild-type and sma-6 mutants (Table 1). The result
suggests that the worm body extended lengthwise. Neuro-
nal expression of sma-6 did not affect either length or
width, as previously shown with aex-3::daf-4 (Table 1). The
pharyngeal and/or intestinal expression of sma-6 by each
tissue-specific promoter (Table 1) or mutated sma-6 pro-
moters (Tables 2 and 3) might increase width. These differ-
ences are very small, however, or undetectable. As Inoue
and Thomas (2000) suggested, different tissues might con-
tribute to the different aspects of body-size regulation, but
we were not able to establish this in our experiments.
Components of the insulin signaling pathway in Dro-
sophila are involved in the regulation of cellular growth
and/or cell size (Bohni et al., 1999; Gao et al., 2000;
Goberdhan et al., 1999; and reviewed in Day and Lawrence,
2000; Leevers, 1999). This might not be the case in C.
elegans, however, because mutants of the insulin receptor
pathway in this organism do not have the Sma phenotype
and have not been shown to have any genetic interaction
with mutants of the Sma pathway.
A recent investigation suggests that endoreduplication is
involved in the body-length determination of C. elegans
(Flemming et al., 2000). Endoreduplication, which consists
of repetitive nuclear DNA synthesis cycles without cell
division, leads to polyploidy. In C. elegans, the main body
hypodermis is syncytial polyploid tissue, but lateral seam
cells, where sma-6 is not expressed, are not (Figs. 1F and
1H). Therefore, regulation of polyploidy might be involved
in body-length determination. The role of DBL-1 signaling
in the pharynx and intestine, where downstream compo-
nents including SMA-6 are expressed, is unclear. Because
endoreduplication is also observed in intestinal nuclei
(Hedgecock and White, 1985; Sulston and Horvitz, 1977),
the intestine might also be involved in the regulation of
body length. The intestine is not the primary tissue defin-
ing body length, however, because intestinally expressed
SMA-6 could not rescue the Sma phenotype (Figs. 2A and
2E and Table 1).
Although clarification of the precise mechanisms of
body-length determination requires further studies, the
present study furthers our understanding of the basis of
intercellular interaction in this morphologically fundamen-
tal and dynamic event.
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